⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL306337 | 1.00 | — | — | |
| Hydrochloric Acid SCHEMBL2872234 | 0.97 | MAPT (0.58) | — | |
| Sulfuric Acid SCHEMBL9067894 | 0.87 | HSD17B10 (0.53) | — | |
| SCHEMBL24709106 | 0.86 | CNR1 (0.50) | — | |
| Phenol SCHEMBL6881606 | 0.85 | NPSR1 (0.57) | — | |
| SCHEMBL13644736 | 0.84 | NPSR1 (0.73) | — | |
| SCHEMBL8170482 | 0.84 | NPSR1 (0.73) | — | |
| SCHEMBL8437804 | 0.84 | NPSR1 (0.50) | — | |
| SCHEMBL628205 | 0.83 | TSHR (0.61) | — | |
| SCHEMBL24146817 | 0.83 | MAPT (0.48) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 31 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116622081-B | Non-noble metal cage MOFs catalyst for producing N-benzamide and preparation method and application thereof | 内蒙古大学 | 2025-06-24 | — | — | CN | claimed |
| CN-119143645-A | Industrial method for synthesizing tolnaftate by one-pot method | 内蒙古幸源新材料科技有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-116622081-A | Non-noble metal cage MOFs catalyst for producing N-benzamide and preparation method and application thereof | 内蒙古大学 | 2023-08-22 | — | — | CN | claimed |
| EP-4619405-A1 | TSPO LIGANDS | The University Of Sydney (AU) | 2025-09-24 | — | — | EP | disclosed |
| US-20250263395-A1 | COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF | MONTE ROSA THERAPEUTICS AG (CH) | 2025-08-21 | — | — | US | disclosed |
| CN-116622081-B | Non-noble metal cage MOFs catalyst for producing N-benzamide and preparation method and application thereof | 内蒙古大学 | 2025-06-24 | — | — | CN | disclosed |
| CN-119875390-A | 3- [ [4- [ (2-R3) R4 amino-3-R2 ] phenyl ] azo ] -R1-nitrobenzene red dye and preparation method thereof | 浙江大恒新材料有限公司 | 2025-04-25 | — | — | CN | disclosed |
| WO-2025016138-A1 | HETEROCYCLIC COMPOUNDS AND USES THEREOF | SUZHOU EOC MEDICAL RESEARCH CO., LTD. (CN) | 2025-01-23 | — | — | WO | disclosed |
| CN-119255992-A | Heterocyclic derivatives, compositions and uses thereof | 北京丹擎医药科技有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-119143645-A | Industrial method for synthesizing tolnaftate by one-pot method | 内蒙古幸源新材料科技有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-119143645-A | Industrial method for synthesizing tolnaftate by one-pot method | 内蒙古幸源新材料科技有限公司 | 2024-12-17 | — | — | CN | disclosed |
| US-20230348369-A1 | NAMPT MODULATORS | CYTOKINETICS, INC. | 2023-11-02 | — | — | US | disclosed |
| CN-116622081-A | Non-noble metal cage MOFs catalyst for producing N-benzamide and preparation method and application thereof | 内蒙古大学 | 2023-08-22 | — | — | CN | disclosed |
| CN-111909083-B | Inhibitors of histone demethylase | 赛尔基因昆蒂赛尔研究公司 | 2023-08-15 | — | — | CN | disclosed |
| WO-2023144793-A1 | POL THETA INHIBITORS | RHIZEN PHARMACEUTICALS AG (CH) | 2023-08-03 | — | — | WO | disclosed |
| CN-116496248-A | Synthesis method of cyantraniliprole impurity | 江苏艾科姆检测有限公司 | 2023-07-28 | — | — | CN | disclosed |
| US-20230167078-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-06-01 | — | — | US | disclosed |
| US-20230139936-A1 | SUBSTITUTED AMINOTHIAZOLES AS DGKZETA INHIBITORS FOR IMMUNE ACTIVATION | BAYER AKTIENGESELLSCHAFT (DE) | 2023-05-04 | — | — | US | disclosed |
| CN-115362003-A | Diacylglycerol kinase modulating compounds | 卡尔那生物科学株式会社 | 2022-11-18 | — | — | CN | disclosed |
| EP-4010080-A1 | HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER | Artios Pharma Limited (GB) | 2022-06-15 | — | — | EP | disclosed |